Document is current
Any future updates will be listed below
-
Authors
Fichtner, Alexander https://orcid.org/0000-0002-9939-4059
Schmidt, Jeremy https://orcid.org/0000-0002-3816-7194
Süsal, Caner https://orcid.org/0000-0003-2521-8201
Carraro, Andrea https://orcid.org/0000-0001-9564-9491
Oh, Jun
Zirngibl, Matthias https://orcid.org/0000-0003-3661-6176
König, Sabine
Guzzo, Isabella https://orcid.org/0000-0003-4960-3083
Weber, Lutz T. https://orcid.org/0000-0003-4116-598X
Awan, Atif https://orcid.org/0000-0002-1615-2602
Krupka, Kai https://orcid.org/0000-0002-0409-5196
Schnitzler, Paul
Hirsch, Hans H. https://orcid.org/0000-0003-0883-0423
Tönshoff, Burkhard https://orcid.org/0000-0002-6598-6910
Höcker, Britta https://orcid.org/0000-0003-4131-2273
-
Funding
Funding for this research was provided by:
Peter Stiftung
Dietmar Hopp Stiftung
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 17 April 2024
Revised: 9 August 2024
Accepted: 12 August 2024
First Online: 11 October 2024
Declarations
:
: The authors of this manuscript have conflicts of interest to disclose. Alexander Fichtner received travel grants from Astellas and Novartis. Lutz T. Weber received a research grant from Chiesi. Hans H. Hirsch reported grants from Moderna, consulting fees of AlCuris, Allovir, Moderna, VeraTx, and Roche, and speaker honoraria by VeraTx, Takeda, Biotest, and Gilead. Burkhard Tönshoff received research grants from Novartis, Astellas, and Chiesi, and consulting fees from Bristol-Myers Squibb, CSL Behring Biotherapies for Life, Vifor, and Chiesi. Britta Höcker received consulting fees from GlaxoSmithKline. Jeremy Schmidt, Caner Süsal, Andrea Carraro, Jun Oh, Matthias Zirngibl, Sabine König, Isabella Guzzo, Atif Awan, Kai Krupka, and Paul Schnitzler have no conflicts of interest.
